Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2.7210
+0.0240
+(0.89%)
As of 8:05:02 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,332
622
240
934
605
Operating Expense
366,617
361,986
350,857
331,214
210,825
Operating Income
-359,285
-361,364
-350,617
-330,280
-210,220
Net Non Operating Interest Income Expense
-147,871
-128,335
-60,807
-14,013
-7,349
Other Income Expense
-80,764
-94,193
-5,862
-5,546
-8,464
Pretax Income
-587,920
-583,892
-417,286
-349,839
-226,033
Tax Provision
-40
-40
34
9
-1,846
Net Income Common Stockholders
-587,794
-583,196
-416,567
-346,790
-221,851
Diluted NI Available to Com Stockholders
-598,347
-583,196
-416,567
-346,790
-221,851
Basic EPS
-0.90
-1.15
-1.04
-0.89
-0.58
Diluted EPS
-0.90
-1.15
-1.04
-0.89
-0.58
Basic Average Shares
681,335.8420
508,635.5920
399,900.3740
389,234.1560
383,179.3760
Diluted Average Shares
684,094.3420
508,635.5920
399,900.3740
389,234.1560
383,179.3760
Total Operating Income as Reported
-360,171
-362,250
-351,298
-330,280
-220,880
Total Expenses
366,617
361,986
350,857
331,214
210,825
Net Income from Continuing & Discontinued Operation
-587,794
-583,196
-416,567
-346,790
-221,851
Normalized Income
-544,080.9743
-534,981.3032
-422,081.9900
-343,186.7200
-211,980.6000
Interest Income
1,008
863
2,708
836
1,725
Interest Expense
148,879
129,198
63,515
14,849
9,074
Net Interest Income
-147,871
-128,335
-60,807
-14,013
-7,349
EBIT
-439,041
-454,694
-353,771
-334,990
-216,959
EBITDA
-421,029
-436,182
-335,511
-320,752
-204,220
Reconciled Depreciation
18,012
18,512
18,260
14,238
12,739
Net Income from Continuing Operation Net Minority Interest
-587,794
-583,196
-416,567
-346,790
-221,851
Total Unusual Items Excluding Goodwill
-43,716
-48,218
6,981
-4,936
-9,950
Total Unusual Items
-43,716
-48,218
6,981
-4,936
-9,950
Normalized EBITDA
-377,313
-387,964
-342,492
-315,816
-194,270
Tax Rate for Calcs
0
0
0.0002
0.0003
0
Tax Effect of Unusual Items
-2.9743
-3.3032
1,466.0100
-1,332.7200
-79.6000
12/31/2020 - 3/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CRO.BE Open Orphan PLC
0.1990
0.00%
6XY.F HBM Holdings Limited
0.6450
0.00%
8JD.F Valbiotis SA
1.2680
-0.62%
OPORF hVIVO plc
0.2400
-31.43%
CRO.F hVIVO plc
0.1740
0.00%
HPHA.F Heidelberg Pharma AG
2.5600
-2.66%
8C5.F Coherus BioSciences, Inc.
0.9456
-7.25%
GBM.F Inovio Pharmaceuticals, Inc.
1.7500
-6.91%
2LB.F Iovance Biotherapeutics, Inc.
3.8200
-1.32%
VICO.ST Vicore Pharma Holding AB (publ)
7.89
-0.38%